Asthma is most commonly treated with inhaled corticosteroids, which are the cornerstone of long-term asthma control. For quick relief during an attack, short-acting bronchodilators like albuterol open the airways within minutes. Most people with asthma use some combination of these two types of medication, and current guidelines recommend that even people with mild asthma use an inhaled corticosteroid rather than relying on a rescue inhaler alone.
Inhaled Corticosteroids: The First-Line Treatment
Inhaled corticosteroids are the most effective and widely used long-term control medications for asthma. They work by reducing inflammation and swelling inside the airways, which is the underlying problem in asthma. Common options include fluticasone, budesonide, beclomethasone, mometasone, and ciclesonide, all delivered through handheld inhalers.
These medications don’t provide instant relief. It can take several days to several weeks of consistent daily use before you feel their full benefit. The goal isn’t to stop a flare-up in progress but to prevent one from happening in the first place. Regular use keeps airway inflammation low, which reduces attacks, nighttime symptoms, and the need for emergency treatment.
Long-term use of inhaled corticosteroids does carry some side effects. The most common is oral thrush, a yeast infection in the mouth that can be prevented by rinsing after each use. At higher doses or over many years, inhaled steroids can affect bone density, skin thickness, and eye health (increasing the risk of cataracts or glaucoma). In children, regular use at low to medium doses has been associated with about half a centimeter less growth per year. These risks are generally managed by using the lowest effective dose.
Rescue Inhalers for Acute Symptoms
Short-acting beta-agonists, most commonly albuterol, are the classic “rescue inhaler.” They relax the muscles around the airways within minutes, making it easier to breathe during an asthma attack or flare-up. Nearly everyone with asthma carries one for emergencies.
However, rescue inhalers only treat symptoms. They don’t reduce the inflammation driving those symptoms, which is why they aren’t recommended as the sole treatment for persistent asthma. If you’re reaching for your rescue inhaler more than twice a week, that’s a sign your underlying inflammation isn’t well controlled.
What Current Guidelines Recommend
The 2024 Global Initiative for Asthma (GINA) guidelines made a significant shift: adults and adolescents with asthma should no longer be treated with a rescue inhaler alone. The preferred approach is a combination inhaler containing a low-dose corticosteroid paired with formoterol, a fast-acting bronchodilator. This single inhaler works both as a daily controller and as relief when symptoms flare.
Two major studies found that using this combination as needed (even in mild asthma) reduced the risk of severe exacerbations by 60 to 64 percent compared to using a rescue inhaler by itself. The logic is straightforward: every time you need relief, you also get a dose of anti-inflammatory medication, which treats the root cause rather than just the symptom.
Combination Inhalers for Moderate Asthma
When a low-dose inhaled corticosteroid alone doesn’t keep symptoms in check, the next step is usually a combination inhaler that pairs a corticosteroid with a long-acting bronchodilator. The bronchodilator keeps airways relaxed for 12 hours or more, while the corticosteroid handles inflammation. Several FDA-approved combination inhalers are available:
- Advair / Airduo: fluticasone plus salmeterol
- Symbicort: budesonide plus formoterol
- Breo Ellipta: fluticasone plus vilanterol
- Dulera: mometasone plus formoterol
FDA trials confirmed that these combinations reduce asthma exacerbations compared to using an inhaled corticosteroid alone. The majority of prevented flare-ups were ones that would have required oral steroids for at least three days, so the practical benefit is real and measurable.
Oral Medications
Leukotriene receptor antagonists, most commonly montelukast (Singulair) and zafirlukast, are pills taken daily to help control asthma. They block inflammatory chemicals called leukotrienes that cause airway tightening, swelling, and the recruitment of immune cells that worsen inflammation over time. These medications are sometimes prescribed alongside inhaled corticosteroids or used for exercise-induced asthma when a rescue inhaler before activity isn’t enough.
Leukotriene blockers are not rescue medications and won’t help during an active attack. They’re generally considered less effective than inhaled corticosteroids for most people, so they tend to be add-on therapy rather than a replacement.
Biologic Therapies for Severe Asthma
For people whose asthma remains uncontrolled despite high-dose inhalers and oral medications, biologic therapies target specific parts of the immune system driving the inflammation. Six biologics are currently FDA-approved for severe asthma:
- Omalizumab: targets the antibody (IgE) responsible for allergic reactions, given by injection every two to four weeks
- Mepolizumab: blocks a signal (IL-5) that promotes a type of white blood cell called eosinophils, injected monthly
- Benralizumab: targets the eosinophil receptor directly, injected monthly for three doses then every eight weeks
- Reslizumab: also blocks IL-5, given as an IV infusion every four weeks
- Dupilumab: blocks a different inflammatory pathway (IL-4), self-injected every two weeks
- Tezepelumab: targets an upstream alarm signal in the airways called TSLP, injected monthly
Which biologic is appropriate depends on the type of inflammation involved. Allergic asthma, eosinophilic asthma, and other subtypes each respond to different targets. Blood tests and allergy testing help determine the best match. These therapies can dramatically reduce flare-ups for people with severe disease, but they’re reserved for cases where standard treatments have failed.
How Inhalers Are Delivered
Most asthma medications reach the lungs through one of two devices: a metered-dose inhaler (the small pressurized canister) or a nebulizer (a machine that turns liquid medication into a fine mist you breathe through a mask or mouthpiece). Research shows that a metered-dose inhaler used with a spacer chamber is equally effective as a nebulizer for most people. Nebulizers are more commonly used for young children or during severe attacks when coordinating an inhaler is difficult.
Trigger Management
Medication controls asthma, but reducing exposure to triggers lowers how often you need it. Removing triggers from the home environment has been shown to decrease hospitalizations, emergency visits, and rescue inhaler use. Practical steps that make a measurable difference include washing bedding regularly in hot water and using allergen-proof mattress and pillow covers to reduce dust mites, fixing leaks and running a dehumidifier to prevent mold growth, keeping pets out of bedrooms, vacuuming and damp dusting weekly, and choosing fragrance-free cleaning products.
Smoke of any kind, including cigarettes, wood fires, and burning leaves, is a potent trigger. Outdoor air quality matters too. Checking pollen counts and air quality indexes before spending time outside, especially during spring and fall or on extremely hot or cold days, helps you plan around your worst triggers. If exercise triggers symptoms, using your rescue inhaler 15 to 30 minutes beforehand can prevent exercise-induced tightening.